Sertindole versus haloperidol: A one year study

被引:0
|
作者
Cunningham, L
Holgate, K
Staser, J
Mack, R
机构
[1] VINE ST CLIN RES,SPRINGFIELD,IL 62701
[2] ABBOTT LABS,ABBOTT PK,IL 60064
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [1] A one-year, controlled cost-effectiveness study comparing sertindole and haloperidol in stable schizophrenic patients
    Chang, R
    Swann, AC
    Becker, L
    Wozniak, PG
    McCarthy, BG
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 117S - 117S
  • [2] One year study: efficacy of haloperidol versus risperidone in the treatment of schizoaffective disorder
    Mladenovic, D. Siladji
    Vukic, S. Drezgic
    Golubovic, B.
    Ivezic, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S496 - S497
  • [3] Sertindole versus haloperidol for schizophrenia - Dr. Zimbroff and colleagues reply
    Zimbroff, DL
    Kane, JM
    Tamminga, CA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (09): : 1303 - 1304
  • [4] SERTINDOLE AND HALOPERIDOL REVISITED; THE PSYCHOMETRIC TRIANGLE
    Bech, Per
    Tanghoj, Per
    Andreasson, Kate T.
    Overo, Kerstin
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 259 - 259
  • [5] Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia
    Zimbroff, DL
    Kane, JM
    Tamminga, CA
    Daniel, DG
    Mack, RJ
    Wozniak, PJ
    Sebree, TB
    Wallin, BA
    Kashkin, KB
    Adan, F
    Ainslie, G
    Allan, E
    Atri, P
    Baker, R
    Beitman, B
    Brown, G
    Canive, J
    Carman, J
    Dott, S
    Edwards, J
    Fenton, W
    Freidli, J
    Funderburg, L
    Ereshefsky, L
    Gladson, M
    Hamilton, J
    Haque, S
    Hartford, J
    Horne, R
    Houck, C
    Jampala, C
    Labelle, A
    Larson, G
    Lesem, M
    Liskow, B
    Makela, E
    Moore, N
    Morphy, M
    Posever, T
    Risch, S
    Rotrosen, J
    Sheehan, D
    Silverstone, P
    Swann, A
    Tapp, A
    Thomas, M
    Volavka, J
    Vora, S
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (06): : 782 - 791
  • [6] The efficacy and safety of three doses of sertindole versus three doses of haloperidol in schizophrenic patients
    Ereshefsky, L
    Mack, RJ
    Morris, DD
    Sebree, TB
    Wallin, B
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 441 - 441
  • [7] Sertindole is superior to haloperidol in cognitive performance in patients with schizophrenia: A comparative study
    Lis, S
    Krieger, S
    Gallhofer, B
    Torre, P
    Mittoux, A
    Menard, F
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S323 - S324
  • [8] A ONE-YEAR STUDY OF HALOPERIDOL DECANOATE IN SCHIZOPHRENIC-PATIENTS
    YOUSSEF, HA
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (06): : 976 - 981
  • [9] Positron emission tomography in schizophrenics treated with sertindole and haloperidol
    Buchsbaum, MS
    Hazlett, E
    Gupta, A
    Wei, CT
    SpiegelCohen, J
    Birren, M
    Haznedar, M
    Fallon, J
    Guich, S
    Bark, N
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 41 : 214 - 214
  • [10] Reduction of hospital days in sertindole treated patients: One year findings
    Ereshefsky, L
    Nabulsi, A
    Silber, C
    Mack, R
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 201 - 202